Detalhe da pesquisa
1.
mAb therapy controls CNS-resident lyssavirus infection via a CD4 T cell-dependent mechanism.
EMBO Mol Med
; 15(10): e16394, 2023 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37767784
2.
Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
Viruses
; 13(3)2021 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33804519
3.
A large library based on a novel (CH2) scaffold: identification of HIV-1 inhibitors.
Biochem Biophys Res Commun
; 387(2): 387-92, 2009 Sep 18.
Artigo
Inglês
| MEDLINE | ID: mdl-19615335
4.
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
J Virol
; 82(14): 6869-79, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18480433
5.
Dynamics of antibody domains studied by solution NMR.
Methods Mol Biol
; 525: 533-43, xv, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19252840
6.
Structure of an isolated unglycosylated antibody C(H)2 domain.
Acta Crystallogr D Biol Crystallogr
; 64(Pt 10): 1062-7, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18931413
7.
Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning.
J Immunol Methods
; 317(1-2): 21-30, 2006 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-17078964
8.
Engineered human antibody constant domains with increased stability.
J Biol Chem
; 284(21): 14203-10, 2009 May 22.
Artigo
Inglês
| MEDLINE | ID: mdl-19307178
9.
Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme.
Br J Haematol
; 128(5): 602-9, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15725080
10.
A dimeric angiogenin immunofusion protein mediates selective toxicity toward CD22+ tumor cells.
J Immunother
; 28(3): 245-51, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15838381
11.
Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein.
Biochem Biophys Res Commun
; 331(2): 595-602, 2005 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-15850802
12.
Generation of a highly stable, internalizing anti-CD22 single-chain Fv fragment for targeting non-Hodgkin's lymphoma.
Int J Cancer
; 107(5): 822-9, 2003 Dec 10.
Artigo
Inglês
| MEDLINE | ID: mdl-14566834